Difference between revisions of "Team:BostonU/Parts"

Line 18: Line 18:
 
#part1 p {
 
#part1 p {
 
   position:relative;
 
   position:relative;
  left:0px;
 
  top:80px;
 
 
   font-size:400%;
 
   font-size:400%;
 
   color:#605E5E;
 
   color:#605E5E;
Line 27: Line 25:
 
#part2 p {
 
#part2 p {
 
   position:relative;
 
   position:relative;
  left:0px;
 
  top:150px;
 
 
   font-size:300%;
 
   font-size:300%;
 
   color:red;
 
   color:red;
Line 36: Line 32:
 
#part3 p {
 
#part3 p {
 
   position:relative;
 
   position:relative;
  top: 200px;
 
 
   font-size:250%;
 
   font-size:250%;
 
   color:#b9b4b4;
 
   color:#b9b4b4;
Line 44: Line 39:
 
div.tab {
 
div.tab {
 
     position:relative;
 
     position:relative;
    left:0px;
 
    top:400px;
 
 
     overflow: hidden;
 
     overflow: hidden;
 
     border: 1px solid #fff0f0;
 
     border: 1px solid #fff0f0;
Line 69: Line 62:
 
     background-color:#fff0f0;
 
     background-color:#fff0f0;
 
     position: relative;
 
     position: relative;
    left:100px;
 
    top:400px;
 
 
     display: none;
 
     display: none;
 
     font-size: 20px;
 
     font-size: 20px;

Revision as of 17:51, 30 June 2017

Registry Parts

Summary

This is a summary of all parts we submitted to registry.

The RFC10 submission standard requires that the restriction site sequences for the Type II restriction enzymes XbaI, EcoRI, PstI, and SpeI are absent from the DNA sequence of a submitted part. This submission standard may require users to alter their part's sequence through the introduction of silent point mutations, but will allow future users to utilize the part in their devices using BioBricks assembly. These four restriction sites were chosen due to their low rate of occurrence in the E. coli genome, which has been one of the most popular chassis in synthetic biology since its inception. This does not mean that Registry users are required to use BioBricks assembly to build their devices; rather, it gives all users and teams the option of utilizing the BioBricks assembly method to string together parts they obtain from the Registry. iGEM Headquarters does not require teams to follow any specified assembly method; rather, we require teams to follow a submission standard in order to be eligible for medals and prizes during the competition. This gives teams the flexibility to utilize any assembly method they desire during the competition while maintaining the usefulness of the Registry by requiring any submitted parts have to adhere to one submission standard (RFC10) for those interested in building devices following the BioBricks assembly method.The RFC10 submission standard requires that the restriction site sequences for the Type II restriction enzymes XbaI, EcoRI, PstI, and SpeI are absent from the DNA sequence of a submitted part. This submission standard may require users to alter their part's sequence through the introduction of silent point mutations, but will allow future users to utilize the part in their devices using BioBricks assembly. These four restriction sites were chosen due to their low rate of occurrence in the E. coli genome, which has been one of the most popular chassis in synthetic biology since its inception. This does not mean that Registry users are required to use BioBricks assembly to build their devices; rather, it gives all users and teams the option of utilizing the BioBricks assembly method to string together parts they obtain from the Registry. iGEM Headquarters does not require teams to follow any specified assembly method; rather, we require teams to follow a submission standard in order to be eligible for medals and prizes during the competition. This gives teams the flexibility to utilize any assembly method they desire during the competition while maintaining the usefulness of the Registry by requiring any submitted parts have to adhere to one submission standard (RFC10) for those interested in building devices following the BioBricks assembly method.The RFC10 submission standard requires that the restriction site sequences for the Type II restriction enzymes XbaI, EcoRI, PstI, and SpeI are absent from the DNA sequence of a submitted part. This submission standard may require users to alter their part's sequence through the introduction of silent point mutations, but will allow future users to utilize the part in their devices using BioBricks assembly. These four restriction sites were chosen due to their low rate of occurrence in the E. coli genome, which has been one of the most popular chassis in synthetic biology since its inception. This does not mean that Registry users are required to use BioBricks assembly to build their devices; rather, it gives all users and teams the option of utilizing the BioBricks assembly method to string together parts they obtain from the Registry. iGEM Headquarters does not require teams to follow any specified assembly method; rather, we require teams to follow a submission standard in order to be eligible for medals and prizes during the competition. This gives teams the flexibility to utilize any assembly method they desire during the competition while maintaining the usefulness of the Registry by requiring any submitted parts have to adhere to one submission standard (RFC10) for those interested in building devices following the BioBricks assembly method.

Description of second submitted part.

Description of third submitted part.